AUG 23, 2019 06:27 AM PDT

New hope for children's brain cancer DIPG

New research published in Nature Communications provides insight on a potential treatment for an aggressive form of brain cancer called Diffuse Intrinsic Pontine Gliomas (DIPG) which usually affects children under 10. There is currently no standard of care for DIPG as the tumor that grows in the brain stem is inoperable; and while the number of patients affected in the U.S. is only approximately 300 annually, most patients do not survive more than a year after diagnosis.

The research comes from a collaboration between scientists at Yale University, University of Iowa, and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. It identifies a pathway that could disrupt the cellular process of DIPG.

DIPG develops in part because of a genetic mutation called PPM1D which affects cell growth and cell stress response. The team behind the study figured out a way to directly target PPM1D via the metabolite called NAD.

"This is really an amazing new way to attack this cancer. We found that the mutated gene PPM1D essentially sets the stage for its own demise," said senior author of the study, Michael Berens, Ph.D., a TGen Deputy Director, head of TGen's DIPG research.

"Our study's potential translational impact should lead to clinical trials and renewed hope for these families who face such a difficult diagnosis for their child," said co-senior author Charles Brenner, Ph.D., Chairman of Biochemistry at the University of Iowa.

Children diagnosed with DIPG typically do not live longer than a year after diagnosis. Photo: Pixabay

Their investigations arose because typical treatments for adult gliomas were not producing the desired results; this urged the researchers to look at the tumors from a new angle, focusing on their vulnerabilities and the role of PPM1D.

As Science Daily reports, the team discovered that “mutated PPM1D silences a gene called NAPRT, which is key to the production of the NAD metabolite. With NAPRT unavailable, the cell switches to another protein needed to create NAD called NAMPT. By using a drug that inhibits the production of NAMPT, researchers found they could essentially starve to death those cancer cells with the PPM1D mutation.”

Another senior author Ranjit Bindra, M.D., Ph.D., Associate Professor of Therapeutic Radiology at the Yale Cancer Center, commented on the hope that the discovery brings. "It is such a devastating disease, and we have been so stymied in our progress for new DIPG therapies. Many drugs have been tested with no success at all. These findings now offer new hope for children with this truly terrible disease," he said.

Sources: Science Daily, Nature Communications

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 22, 2020
Cancer
JAN 22, 2020
Not worth the risk: e-cigs and lung inflammation
E-cigarette use is on the rise and according to new research published in the journal Cancer Prevention Research, even short-term usage of e-cigs can be a ...
JAN 22, 2020
Cancer
JAN 22, 2020
Diet and prostate cancer
It is difficult to pinpoint a specific diet to its benefits or detriments, largely because so many other factors often go along with diet. For example, it ...
JAN 22, 2020
Cancer
JAN 22, 2020
When the numbers don't match: inaccuracy in late state breast cancer survival estimates
According to the World Health Organization, about 2.1 million women are diagnosed with breast cancer annually. It is the cancer that most affects women and...
JAN 22, 2020
Health & Medicine
JAN 22, 2020
Are Popular Gyms Promoting Indoor Tanning?
You might assume that by now, most humans are aware of the dangers of indoor tanning beds. However, many popular gyms include tanning beds as a perk of mem...
JAN 22, 2020
Health & Medicine
JAN 22, 2020
Cancer Death Rates Declining in U.S., According to New Report
In the United States, the death rate from cancer has declined, according to a new report released today by the American Cancer Society. The video below sum...
JAN 22, 2020
Cancer
JAN 22, 2020
The anti-cancer properties of bitter melon
New research published in the journal Cell Communication and Signaling suggests that bitter melon, also known as bitter gourd, may have anti-cancer propert...
Loading Comments...